查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1986650

体外诊断市场规模、份额和趋势分析报告：按产品、最终用途、技术、检测地点、应用、地区和细分市场预测（2026-2033 年）

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By End Use (Hospitals, Laboratory), By Technology, By Test Location, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10个工作天内

价格

体外诊断市场概述

全球体外诊断市场预计到 2025 年价值 1,062.9 亿美元，预计到 2033 年将达到 1,281.8 亿美元。

预计从 2026 年到 2033 年，该市场将以 2.40% 的复合年增长率成长。这一市场成长是由全球对准确、快速和个人化诊断解决方案的需求不断增长所驱动的。

市场成长的关键驱动因素包括慢性病和感染疾病病率的上升、诊断技术的进步以及以价值为导向的医疗保健模式的转变，这种模式强调早期检测和预防医学。将数位健康、人工智慧和数据分析整合到诊断平台中，可以提高检测准确性和临床决策水准。此外，就地检验和个人化医疗的普及，加上新兴市场的成长和疫情防范能力的提升，正在持续推动市场渗透，并为相关人员创造重要的商业机会。预计在预测期内，慢性病、感染疾病以及阿兹海默症、透纳氏症和帕金森氏症等遗传性疾病盛行率的上升将进一步推动市场需求。

根据美国疾病管制与预防中心（CDC）的数据，癌症、糖尿病等慢性疾病以及慢性肾臟病和气喘等呼吸道疾病，占美国每年死亡人数的70%。大约十分之六的美国成年人可能患有慢性疾病。这些慢性疾病每年造成美国医疗保健系统4.1兆美元的损失。 2024年，美国确诊病例62万例，死亡213例，主要集中在美洲，其中巴西、巴拉圭和阿根廷的病例负担最重。亚洲确诊病例较多，尤其是印度和巴基斯坦，塞内加尔是非洲唯一出现感染病例的国家。欧洲方面，法国报告了一例本土传播病例，法属留尼旺岛旺岛通报了118例。

预计在准确性、成本效益和便携性方面的技术进步将成为该市场的主要驱动力。领先的市场参与企业正检测套组线。各公司加大研发投入和合作项目也推动了创新产品的上市。小型化、奈米技术、微流体和云端连接的即时诊断技术的进步，使得分子层面的诊断更加经济实惠、易于使用且更加灵敏。配备多种生物感测平台的智慧型手机连接读取器可实现即时现场诊断。 3D列印技术提高了即时诊断设备的製造流程和性能，而具备无线通讯功能的柔性感测器则可实现对患者的即时监测，从而应用于预防医学和感染疾病疫情应对。这些创新表明，即时分子诊断技术取得了显着进展，并展现了对医疗保健的潜在影响。

预计用于感染疾病诊断临床研究的外部资金增加将推动市场成长，因为资金对于推进产品开发至关重要。例如，2025年1月，罗德岛医院从CARB-X获得100万美元的津贴，用于支持开发一种直接针对肺炎致病菌的血液PCR检测方法，旨在改善下呼吸道感染疾病（LRTI）的诊断。这项研发满足了感染疾病分子诊断市场对快速且准确诊断的迫切需求，有助于对抗抗药性并改善患者照护。

然而，分子检测的高昂成本是限制该市场成长的主要因素之一。缺乏可比产品是造成价格高昂的另一个原因。不同分子诊断产品的价格差异显着，进一步加剧了这个问题。此外，分子诊断设备的高成本仍是市场成长的一大挑战。例如，Bio-Rad Laboratories 的 CFX Connect PCR 检测系统售价约为 17,995 美元，而 Thermo Fisher Scientific 的 7900 HT qPCR 系统售价在 20,000 美元至 30,000 美元之间。数位 PCR (dPCR) 仪器具有更高的准确性和灵敏度，但价格甚至高于即时PCR系统。手动 dPCR 仪器的价格通常在 65,000 美元至 70,000 美元之间，而自动化 dPCR 系统的价格可能超过 100,000 美元。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：体外诊断市场的影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 体外诊断市场分析工具
    • 波特的分析
    • PESTEL 分析
  • 体外诊断试剂与实验室自建检测报销概述
  • 价格分析

第四章：体外诊断市场：依产品分類的估算与趋势分析

  • 体外诊断市场：产品特定波动分析（2025 年和 2033 年）
  • 装置
  • 试剂
  • 服务

第五章：体外诊断市场：依技术分類的估算与趋势分析

  • 体外诊断市场：基于技术的波动分析，2025 年和 2033 年
  • 免疫检测
    • 装置
    • 试剂
    • 服务
  • 血液学
    • 装置
    • 试剂
    • 服务
  • 临床化学
    • 装置
    • 试剂
    • 服务
  • 分子诊断
    • 装置
    • 试剂
    • 服务
  • 凝血
    • 装置
    • 试剂
    • 服务
  • 微生物学
    • 装置
    • 试剂
    • 服务
  • 其他的
    • 装置
    • 试剂
    • 服务

第六章：体外诊断市场：按应用分類的估算与趋势分析

  • 体外诊断市场：基于应用领域的波动分析，2025 年和 2033 年
  • 感染疾病
  • 糖尿病
  • 肿瘤学/癌症
  • 循环系统
  • 肾臟病学
  • 自体免疫疾病
  • 药物检测
  • 其他的

第七章 体外诊断市场：依检测地点分類的估算与趋势分析

  • 体外诊断市场：按检测地点分類的波动分析（2025 年和 2033 年）
  • 照护现场
  • 居家照护
  • 其他的

第八章：体外诊断市场：依最终用途分類的估算与趋势分析

  • 体外诊断市场：依最终用途分類的波动分析（2025 年和 2033 年）
  • 医院
  • 检查室
  • 居家医疗
  • 其他的

第九章：体外诊断市场：区域估算与趋势分析

  • 体外诊断市场：区域份额（2025 年和 2033 年）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第十章 竞争格局

  • 主要市场参与企业近期趋势及影响分析
  • 公司分类
  • 全球企业市场占有率分析（2025 年）
  • 企业热力图分析
  • 策略规划
    • 业务拓展
    • 併购
    • 伙伴关係和联盟
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
Product Code: 978-1-68038-080-4

In Vitro Diagnostics Market Summary

The global in vitro diagnostics market size was estimated at USD 106.29 billion in 2025 and is projected to reach USD 128.18 billion by 2033, growing at a CAGR of 2.40% from 2026 to 2033. This market growth is attributed to the rising global demand for accurate, rapid, and personalized diagnostic solutions.

Some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the shift toward value-based healthcare emphasizing early detection and preventive care. The integration of digital health, AI, and data analytics into diagnostic platforms enhances test accuracy and clinical decision-making. In addition, the expansion of point-of-care testing, personalized medicine, and emerging markets, coupled with heightened pandemic preparedness, continues to drive market penetration, creating significant opportunities for industry stakeholders. The increase in the prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer's disease, Turner syndrome, & Parkinson's disease, is expected to boost the market demand during the forecast period.

According to the CDC, chronic diseases such as cancer & diabetes, and chronic kidney & respiratory diseases, such as asthma, are responsible for 7 in 10 deaths in the U.S. each year. Around 6 out of 10 adults are likely to suffer from a chronic disease in the U.S. These chronic diseases account for USD 4.1 trillion in annual healthcare costs in the U.S. In 2024, 620,000 cases and 213 deaths were detected, primarily in the Americas, with Brazil, Paraguay, and Argentina reporting the highest burdens. Asia saw significant cases, particularly in India and Pakistan, while Senegal was the only affected African country. Europe recorded one locally acquired case in France and 118 cases in La Reunion.

Technological advancements in terms of accuracy, cost-effectiveness, and portability are expected to be among the high-impact rendering drivers for this market. Leading market participants are updating their range of testing options by undertaking R&D initiatives for the development of kits that target life-threatening conditions or by entering into collaborations with other kit manufacturing players. Innovative product launches in the market are also a result of the rising number of R&D and partnership programs by players. Advancements in miniaturization, nanotechnology, microfluidics, and cloud-connected POC diagnostics are making molecular-level diagnostics more affordable, user-friendly, and sensitive. Smartphone-integrated readers with diverse biosensing platforms enable onsite and on-time diagnoses. 3D printing enhances POC device fabrication and performance, while flexible sensors with wireless communication allow real-time patient monitoring for preventative healthcare and disease outbreaks. These innovations signify significant progress in POC molecular diagnostics and its potential impact on healthcare.

The increase in external funding for clinical studies in infectious disease molecular diagnostics is expected to drive market growth, as funding is crucial in advancing product development. For example, in January 2025, Rhode Island Hospital received a USD 1 million grant from CARB-X to support the development of a direct-from-blood PCR test for pneumonia-causing bacteria, aiming to improve diagnostics for lower respiratory tract infections (LRTIs). This advancement addresses the urgent need for rapid, accurate diagnostics to combat antibiotic resistance and enhance patient care in the infectious disease molecular diagnostics market.

However, high prices associated with molecular tests are one of the major factors impeding this market. Lack of comparable products is another reason for the hiked prices. The significant price variations for different applications of each molecular diagnostic product further compound this problem. Moreover, the high cost of molecular diagnostic instruments remains a key challenge for market growth. For example, Bio-Rad Laboratories' CFX Connect PCR Detection System is priced at approximately USD 17,995, while Thermo Fisher Scientific's 7900 HT qPCR system ranges between USD 20,000 and USD 30,000. Digital PCR (dPCR) instruments offer greater accuracy and sensitivity and are even more expensive than real-time PCR systems. Manual dPCR instruments typically cost between USD 65,000 and USD 70,000, whereas automated dPCR systems can exceed USD 100,000.

Global In Vitro Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global in vitro diagnostics market report based on products, technology, application, test location, end use, and region.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Instruments
  • Reagents
  • Services
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services
  • Application Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Other applications
  • Test Location Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Point of Care
  • Home-care
  • Services
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Hospitals
  • Laboratory
  • Home Care
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Introduction of Technologically Advanced Products
      • 3.2.1.2. Increasing Demand for PoC Testing
      • 3.2.1.3. Growing Prevalence of Target Diseases
      • 3.2.1.4. Increasing External Funding for R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. High Capital Investment
      • 3.2.2.3. High Prices of Molecular Diagnostic Tests
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
    • 3.2.5. Distribution Channel
      • 3.2.5.1. Direct Sales
      • 3.2.5.2. Distributors Network
      • 3.2.5.3. E-commerce and Online Platforms
      • 3.2.5.4. Major Distributors
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Reimbursement Overview of IVDs and LDTs
  • 3.5. Pricing Analysis

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, USD Billion, 2025 & 2033
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, USD Billion, 2025 & 2033
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Units)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, USD Billion, 2025 & 2033
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, USD Billion, 2025 & 2033
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, USD Billion, 2025 & 2033
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2025 & 2033, USD Billion
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.2. U.K.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2025
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Bio-Rad Laboratories, Inc
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. BIOMERIEUX
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. BD
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. QIAGEN
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. F. Hoffmann-La Roche Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Danaher
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Quest Diagnostics Incorporated
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Agilent Technologies, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 29 Mexico In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 35 Europe In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 37 U.K. In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 39 U.K. In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 40 U.K. In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 45 Germany America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 47 France In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 50 France In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 55 Spain In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 59 Italy In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 60 Italy In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 66 Asia Pacific In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 68 China In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 70 China In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 71 China In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 76 Japan In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 78 India In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 80 India In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 81 India In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 86 South Korea In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 88 Australia In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 89 Australia In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 90 Australia In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 91 Australia In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 93 Latin America In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 94 Latin America In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 96 Latin America In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 97 Latin America In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 99 Brazil In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 101 Brazil In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 102 Brazil In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 104 Argentina In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 106 Argentina In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 107 Argentina In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 109 MEA In Vitro Diagnostics Market, By Country, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 110 MEA In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 111 MEA In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 112 MEA In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 113 MEA In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 115 South Africa In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 117 South Africa In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 118 South Africa In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 120 UAE In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 121 UAE In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 122 UAE In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 123 UAE In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion million
  • Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 128 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion
  • Table 130 Kuwait In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 131 Kuwait In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 132 Kuwait In Vitro Diagnostics Market, By Application, 2021 - 2033 USD Billion
  • Table 133 Kuwait In Vitro Diagnostics Market, By End-use, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Table 134 Kuwait In Vitro Diagnostics Market, By Test Location, 2021 - 2033 USD Billion

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostics market snapshot
  • Fig. 10 Parent market outlook, 2025
  • Fig. 11 In vitro diagnostics market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostics market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 IVD market: Product outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 21 Reagents market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 22 Services market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology movement analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 28 Services market for immunoassay estimates and forecast, 2021 - 2033 USD billion
  • Fig. 29 Hematology market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 31 Reagents market for hematology estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 32 Services market for hematology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 33 Clinical chemistry market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2021 - 2033 USD billion
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2021 - 2033 USD billion
  • Fig. 41 Coagulation market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 44 Services market for coagulation estimates and forecast, 2021 - 2033 USD billion
  • Fig. 45 Microbiology market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 48 Services market for microbiology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 49 Others market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 50 Instruments market estimates and forecast, 2021 - 2033 USD billion, volume, number of instruments, in thousands
  • Fig. 51 Reagents market estimates and forecast, 2021 - 2033 USD billion, volume, reagents, number of tests in million
  • Fig. 52 Services market for other technology estimates and forecast, 2021 - 2033 USD billion
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 56 Diabetes market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 57 Oncology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 58 Cardiology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 59 Nephrology market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 61 Drug testing market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 62 Others market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 63 IVD market: End-use outlook and key takeaways
  • Fig. 64 IVD treatment market: End-use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 66 Laboratory market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 67 Home care market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 68 Other market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 69 IVD market: test location outlook and key takeaways
  • Fig. 70 IVD treatment market: Test location movement analysis
  • Fig. 71 Point-of-care market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 72 Homecare market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 73 Others market estimates and forecast, 2021 - 2033 USD billion
  • Fig. 74 IVD Market: Regional outlook and key takeaways
  • Fig. 75 IVD market: Regional movement analysis
  • Fig. 76 North America
  • Fig. 77 North America. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 86 U.K. key country dynamics
  • Fig. 87 UK market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 90 Spain key country dynamics
  • Fig. 91 Spain market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 104 Japan key country dynamics
  • Fig. 105 Japan market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 106 China key country dynamics
  • Fig. 107 China. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 108 India key country dynamics
  • Fig. 109 India. market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 112 Thailand key country dynamics
  • Fig. 113 Thailand market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 122 MEA
  • Fig. 123 MEA market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 126 UAE key country dynamics
  • Fig. 127 UAE market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 128 Saudi Arabia key country dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 130 Kuwait key country dynamics
  • Fig. 131 Kuwait market estimates and forecast, 2021 - 2033 (USD billion) (volume, number of instruments, in thousands, volume, reagents, number of tests in million)